These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 10839805)

  • 21. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
    Lang GA; Maltsev SD; Besra GS; Lang ML
    Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition.
    Wei DG; Curran SA; Savage PB; Teyton L; Bendelac A
    J Exp Med; 2006 May; 203(5):1197-207. PubMed ID: 16651387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors.
    Brigl M; van den Elzen P; Chen X; Meyers JH; Wu D; Wong CH; Reddington F; Illarianov PA; Besra GS; Brenner MB; Gumperz JE
    J Immunol; 2006 Mar; 176(6):3625-34. PubMed ID: 16517731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.
    Kjer-Nielsen L; Borg NA; Pellicci DG; Beddoe T; Kostenko L; Clements CS; Williamson NA; Smyth MJ; Besra GS; Reid HH; Bharadwaj M; Godfrey DI; Rossjohn J; McCluskey J
    J Exp Med; 2006 Mar; 203(3):661-73. PubMed ID: 16505140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of alphaGalCer-induced TCRValpha24 Vbeta11(+) natural killer T cells on NK cell cytotoxicity in umbilical cord blood.
    Ueda Y; Hagihara M; Gansuvd B; Yu Y; Masui A; Okamoto A; Higuchi A; Tazume K; Kato S; Hotta T
    Cancer Immunol Immunother; 2003 Oct; 52(10):625-31. PubMed ID: 12802518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
    Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
    J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size.
    Matsuda JL; Gapin L; Fazilleau N; Warren K; Naidenko OV; Kronenberg M
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12636-41. PubMed ID: 11592984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.
    Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y
    J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
    Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
    Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD1d1 displayed on cell size beads identifies and enriches an NK cell population negatively regulated by CD1d1.
    Huang MM; Borszcz P; Sidobre S; Kronenberg M; Kane KP
    J Immunol; 2004 May; 172(9):5304-12. PubMed ID: 15100269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
    Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
    J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells.
    van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS
    Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.
    Baron JL; Gardiner L; Nishimura S; Shinkai K; Locksley R; Ganem D
    Immunity; 2002 Apr; 16(4):583-94. PubMed ID: 11970881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
    Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
    J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
    Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.
    Patel O; Pellicci DG; Uldrich AP; Sullivan LC; Bhati M; McKnight M; Richardson SK; Howell AR; Mallevaey T; Zhang J; Bedel R; Besra GS; Brooks AG; Kjer-Nielsen L; McCluskey J; Porcelli SA; Gapin L; Rossjohn J; Godfrey DI
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19007-12. PubMed ID: 22065767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
    Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
    Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
    Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
    Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.